GB2543374B - Personalised media - Google Patents

Personalised media

Info

Publication number
GB2543374B
GB2543374B GB1607940.2A GB201607940A GB2543374B GB 2543374 B GB2543374 B GB 2543374B GB 201607940 A GB201607940 A GB 201607940A GB 2543374 B GB2543374 B GB 2543374B
Authority
GB
United Kingdom
Prior art keywords
personalised
media
personalised media
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB1607940.2A
Other versions
GB201607940D0 (en
GB2543374A (en
Inventor
Benson Roderick
Griffiths Gareth
Dutko-Gwozdz Joanna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imagen Therapeutics Ltd
Original Assignee
Imagen Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imagen Therapeutics Ltd filed Critical Imagen Therapeutics Ltd
Publication of GB201607940D0 publication Critical patent/GB201607940D0/en
Publication of GB2543374A publication Critical patent/GB2543374A/en
Application granted granted Critical
Publication of GB2543374B publication Critical patent/GB2543374B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB1607940.2A 2015-05-08 2016-05-06 Personalised media Active GB2543374B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1507894.2A GB201507894D0 (en) 2015-05-08 2015-05-08 Personalised media

Publications (3)

Publication Number Publication Date
GB201607940D0 GB201607940D0 (en) 2016-06-22
GB2543374A GB2543374A (en) 2017-04-19
GB2543374B true GB2543374B (en) 2018-11-07

Family

ID=53489330

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1507894.2A Ceased GB201507894D0 (en) 2015-05-08 2015-05-08 Personalised media
GB1607940.2A Active GB2543374B (en) 2015-05-08 2016-05-06 Personalised media

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB1507894.2A Ceased GB201507894D0 (en) 2015-05-08 2015-05-08 Personalised media

Country Status (2)

Country Link
GB (2) GB201507894D0 (en)
WO (1) WO2016181114A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108707582A (en) * 2018-05-24 2018-10-26 上海赫佰生物医药科技有限公司 A kind of high-efficient culture method and its application of the tumour cell in body fluid source

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077079A1 (en) * 2001-01-31 2004-04-22 Peter Storgaard Improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
WO2011053690A1 (en) * 2009-10-30 2011-05-05 The University Of North Carolina At Chapel Hill Multipotent stem cells from the extrahepatic billary tree and methods of isolating same
WO2012107447A2 (en) * 2011-02-11 2012-08-16 Fondazione I.R.C.C.S. Istituto Neurologico "Carlo Besta" Culture medium and method for the extraction, isolation and propagation of animal cell lines of high purity and highly purified continuous animal cell lines thus obtained
WO2012131733A2 (en) * 2011-03-31 2012-10-04 Godavari Biorefineries Limited Media compositions, method of initiating and enriching cultures of stem cells and/or cancer stem-like cells
WO2013050962A1 (en) * 2011-10-04 2013-04-11 Mitra Biotech Private Limited Ecm composition, tumor microenvironment platform and methods thereof
WO2014114465A1 (en) * 2013-01-24 2014-07-31 Bernardo Nadal-Ginard Modulation of cardiac stem-progenitor cell differentiation, assays and uses thereof
WO2015181185A1 (en) * 2014-05-26 2015-12-03 Universitätsspital Basel In vitro culturing or expanding human or animal tissue
US20160369241A1 (en) * 2015-03-23 2016-12-22 Yao Tang Methods of primary tissue culture and drug screening using autologous serum and fluids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443546A (en) * 1980-07-07 1984-04-17 The Beth Israel Hospital Association Process and composition for propagating mammalian cells
KR100908481B1 (en) * 2006-04-24 2009-07-21 코아스템(주) Mesenchymal stem cell culture medium and culture method of mesenchymal stem cells using the same
WO2010149597A2 (en) * 2009-06-18 2010-12-29 Cellartis Ab 3D CULTURING SYSTEMS FOR GROWTH AND DIFFERENTIATION OF HUMAN PLURIPOTENT STEM (hPS) CELLS
DE102009047146B4 (en) 2009-11-25 2012-07-19 Ulrich Pachmann A method for predicting the response of a tumor disease to a therapeutic intervention
WO2013069010A1 (en) 2011-11-10 2013-05-16 Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods for individually optimizing a cancer treatment
CA2914026A1 (en) 2013-06-04 2014-12-11 University Of Miami Assays, methods and kits for analyzing sensitivity and resistance to anti-cancer drugs, predicting a cancer patient's prognosis, and personalized treatment strategies

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077079A1 (en) * 2001-01-31 2004-04-22 Peter Storgaard Improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
WO2011053690A1 (en) * 2009-10-30 2011-05-05 The University Of North Carolina At Chapel Hill Multipotent stem cells from the extrahepatic billary tree and methods of isolating same
WO2012107447A2 (en) * 2011-02-11 2012-08-16 Fondazione I.R.C.C.S. Istituto Neurologico "Carlo Besta" Culture medium and method for the extraction, isolation and propagation of animal cell lines of high purity and highly purified continuous animal cell lines thus obtained
WO2012131733A2 (en) * 2011-03-31 2012-10-04 Godavari Biorefineries Limited Media compositions, method of initiating and enriching cultures of stem cells and/or cancer stem-like cells
WO2013050962A1 (en) * 2011-10-04 2013-04-11 Mitra Biotech Private Limited Ecm composition, tumor microenvironment platform and methods thereof
WO2014114465A1 (en) * 2013-01-24 2014-07-31 Bernardo Nadal-Ginard Modulation of cardiac stem-progenitor cell differentiation, assays and uses thereof
WO2015181185A1 (en) * 2014-05-26 2015-12-03 Universitätsspital Basel In vitro culturing or expanding human or animal tissue
US20160369241A1 (en) * 2015-03-23 2016-12-22 Yao Tang Methods of primary tissue culture and drug screening using autologous serum and fluids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Experimental Hematology Vol. 32, No. 12, 1st Dec 2004, Stute et al "Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use", p1212-1215. *

Also Published As

Publication number Publication date
GB201507894D0 (en) 2015-06-24
GB201607940D0 (en) 2016-06-22
WO2016181114A1 (en) 2016-11-17
GB2543374A (en) 2017-04-19

Similar Documents

Publication Publication Date Title
GB2558478B (en) Copy-Redirect on write
EP3378235A4 (en) Media streaming
GB2521883B (en) Media controller
GB2538755B (en) Media routing
GB201614356D0 (en) Media buffering
EP3119611A4 (en) Printable media
ZA201606446B (en) Filter media construction
GB201408653D0 (en) Moonpool
GB201607575D0 (en) Augmented media
GB201405948D0 (en) Enhanced media quality management
GB201403568D0 (en) Dense media deparation method
EP3265321A4 (en) Printable media
IL267558B (en) Perfusion media
EP3198471A4 (en) Media organization
EP3294560A4 (en) Printable media
GB2537722B (en) Booklet
GB201513196D0 (en) Media device
GB201517358D0 (en) Media filter
GB2543374B (en) Personalised media
GB201401171D0 (en) Purification medium
GB201620722D0 (en) Media streaming system
PL3183486T3 (en) Preassembled media line
GB201615253D0 (en) Media
GB201613815D0 (en) Adaptive media combined with medicines
GB201506424D0 (en) Personalised contact